Democratic Republic of the Congo
Goal: Increase access, demand and utilization of the 13 life-saving commodities and improve child health and reproductive health interventions.
DRC received an initial grant in support of a national plan to expand access to the 13 life-saving commodities. It supported several interventions including: increasing regulatory efficiency by listing manufacturers of 12 products, in view of their new drug application, and including misoprostol, amoxicillin disposable tablets and chlorhexidine on the national Essential Medicines List.
Quality assurance was strengthened by training 30 auditors in quality assurance for pharmaceutical laboratories – and audited ten of those laboratories.
In order to increase health worker performance, treatment guidelines for amoxicillin dispersible tablets, chlorhexidine, misoprostol, emergency contraception and female condoms have been developed or updated and disseminated.
As part of the grant approved in 2014 through an RMNCH Country Engagement Process, DRC scaled-up ‘family kits’ through Community Health Workers. This is a joint program carried out in close coordination and collaboration with the Global Fund, GAVI, the World Bank and others. A large portion of the support went towards the procurement of zinc, ORS and amoxicillin and packaging them for distribution.
Activities to support the strengthening of the surveillance of maternal deaths and response started in the Kwango Provincial Health Division in 14 Health Zones. This will further inform progressive scale-up.
The country team also purchased family planning inputs, prepared a training for family planning service providers, and developed tools, guides and checklists into the four DRC languages.
The graph below summarizes the country context and the achievements to date with the support that the country has received.